MODEL AA-8565CV-ACT MODEL AA-8565CV
emergency response safety kit kit |
| Product Information |
| Product Type | MEDICAL DEVICE | Item Code (Source) | NHRIC:27860-013 |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NHRIC:27860-013-16 | 1 in 1 PACKAGE; Type 1: Convenience Kit of Co-Package | | |
|
| Quantity of Parts |
| Part # | Package Quantity | Total Product Quantity |
| Part 1 | | 1 |
| Part 2 | | 1 |
| Part 3 | | 1 |
| Part 4 | | 1 |
| Part 5 | | 1 |
| Part 6 | | 1 |
| Part 7 | | 1 |
| Part 8 | | 1 |
| Part 9 | | 1 |
| Part 10 | | 1 |
| Part 11 | | 1 |
| Part 12 | | 1 |
| Part 13 | | 1 |
| Part 14 | | 1 |
| Part 15 | | 1 |
| Part 16 | | 1 |
| Part 17 | | 1 |
| Part 18 | | 1 |
| Part 19 | | 1 |
| Part 20 | | 1 |
| Part 21 | | 1 |
| Part 22 | | 1 |
| Part 23 | | 1 |
| Part 24 | | 1 |
| Part 25 | | 1 |
| Part 26 | | 1 |
| Part 27 | | 1 |
| Part 28 | | 1 |
| Part 29 | | 1 |
|
| Part 1 of 29 |
SODIUM CHLORIDE
sodium chloride injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 0338-0049 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) | SODIUM CHLORIDE | 9 g in 1000 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA016677 | 12/09/1970 | |
|
| Part 2 of 29 |
SODIUM CHLORIDE
sodium chloride injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 0264-7800 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) | SODIUM CHLORIDE | 0.9 g in 100 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA019635 | 03/09/1988 | |
|
| Part 3 of 29 |
ATROPINE SULFATE
atropine sulfate injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 0409-4910 |
| Route of Administration | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, ENDOTRACHEAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) | ATROPINE SULFATE | 0.1 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA021146 | 01/19/2006 | |
|
| Part 4 of 29 |
ATROPINE SULFATE
atropine sulfate injection |
|
| Product Information |
| Item Code (Source) | NDC: 76329-3339 |
| Route of Administration | PARENTERAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| Atropine Sulfate (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) | Atropine Sulfate | 0.1 mg in 1 mL |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 06/01/2000 | |
|
| Part 5 of 29 |
DEXTROSE MONOHYDRATE
dextrose monohydrate injection |
|
| Product Information |
| Item Code (Source) | NDC: 76329-3301 |
| Route of Administration | PARENTERAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) | DEXTROSE MONOHYDRATE | 500 mg in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| Water (UNII: 059QF0KO0R) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 06/01/2000 | |
|
| Part 6 of 29 |
DEXTROSE
dextrose monohydrate injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 0409-6648 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) | DEXTROSE MONOHYDRATE | 25 g in 50 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA019445 | 12/02/2005 | |
|
| Part 7 of 29 |
NITROGLYCERIN
nitroglycerin tablet |
|
| Product Information |
| Item Code (Source) | NDC: 68462-639 |
| Route of Administration | SUBLINGUAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) | NITROGLYCERIN | 0.4 mg |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| CALCIUM STEARATE (UNII: 776XM7047L) | |
| CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) | |
| LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) | |
| SILICA DIMETHYL SILYLATE (UNII: EU2PSP0G0W) | |
|
| Product Characteristics |
| Color | white (white to off white) | Score | no score |
| Shape | ROUND (Flat faced) | Size | 4mm |
| Flavor | | Imprint Code |
2;C
|
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA206391 | 08/19/2017 | |
|
| Part 8 of 29 |
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride injection |
|
| Product Information |
| Item Code (Source) | NDC: 0641-0376 |
| Route of Administration | INTRAMUSCULAR, INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) | DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA080817 | 11/27/1972 | |
|
| Part 9 of 29 |
EPINEPHRINE
epinephrine injection, solution, concentrate |
|
| Product Information |
| Item Code (Source) | NDC: 54288-103 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| Epinephrine (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) | Epinephrine | 1 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA205029 | 08/08/2014 | |
|
| Part 10 of 29 |
ALCOHOL PREP
isopropyl alcohol swab |
|
| Product Information |
| Item Code (Source) | NDC: 67777-121 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302) | ISOPROPYL ALCOHOL | 0.7 mL in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
|
| Product Characteristics |
| Color | | Score | |
| Shape | RECTANGLE | Size | |
| Flavor | | Imprint Code | |
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC Monograph Drug | M003 | 07/01/2010 | |
|
| Part 11 of 29 |
MOORE MEDICAL NON ASPIRIN
acetaminophen tablet, film coated |
|
| Product Information |
| Item Code (Source) | NDC: 55670-467 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) | ACETAMINOPHEN | 325 mg |
|
|
|
| Product Characteristics |
| Color | white (white) | Score | no score |
| Shape | ROUND (ROUND) | Size | 10mm |
| Flavor | | Imprint Code |
AZ;234
|
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC Monograph Drug | M013 | 12/30/2008 | |
|
| Part 12 of 29 |
ASPIRIN
aspirin tablet, film coated |
|
| Product Information |
| Item Code (Source) | NDC: 55670-131 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) | ASPIRIN | 325 mg |
|
|
|
| Product Characteristics |
| Color | white (white) | Score | no score |
| Shape | ROUND (ROUND) | Size | 10mm |
| Flavor | | Imprint Code |
TCL;011
|
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC Monograph Drug | M013 | 12/30/2008 | 08/31/2022 |
|
| Part 13 of 29 |
VENTOLIN
HFA
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 0173-0682 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA020983 | 06/09/2006 | |
|
| Part 14 of 29 |
ALBUTEROL SULFATE
HFA
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 66993-019 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA authorized generic | NDA020983 | 01/15/2019 | |
|
| Part 15 of 29 |
ALBUTEROL SULFATE
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 45802-088 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| ALCOHOL (UNII: 3K9958V90M) | |
| NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA203760 | 02/26/2020 | |
|
| Part 16 of 29 |
ALBUTEROL SULFATE
HFA
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 0093-3174 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| NORFLURANE (UNII: DH9E53K1Y8) | |
| ALCOHOL (UNII: 3K9958V90M) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA021457 | 01/16/2019 | |
|
| Part 17 of 29 |
ALBUTEROL SULFATE
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 0254-1007 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 108 ug |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA authorized generic | NDA020503 | 04/03/2019 | |
|
| Part 18 of 29 |
PROAIR
HFA
albuterol sulfate aerosol, metered |
|
| Product Information |
| Item Code (Source) | NDC: 59310-579 |
| Route of Administration | RESPIRATORY (INHALATION) |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| NORFLURANE (UNII: DH9E53K1Y8) | |
| ALCOHOL (UNII: 3K9958V90M) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA021457 | 12/03/2012 | |
|
| Part 19 of 29 |
POVIDONE-IODINE
povidone-iodine solution |
|
| Product Information |
| Item Code (Source) | NDC: 46414-7777 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4) | IODINE | 10 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| unapproved drug other | | 02/14/1976 | |
|
| Part 20 of 29 |
BZK PADS
benzalkonium chloride swab |
|
| Product Information |
| Item Code (Source) | NDC: 67777-245 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) | BENZALKONIUM CHLORIDE | 1.3 mg in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | |
|
| Product Characteristics |
| Color | | Score | |
| Shape | RECTANGLE | Size | |
| Flavor | | Imprint Code | |
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC Monograph Drug | M003 | 04/05/2011 | |
|
| Part 21 of 29 |
SOLU-CORTEF
hydrocortisone sodium succinate injection, powder, for solution |
|
| Product Information |
| Item Code (Source) | NDC: 0009-0825 |
| Route of Administration | INTRAMUSCULAR, INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| HYDROCORTISONE SODIUM SUCCINATE (UNII: 50LQB69S1Z) (HYDROCORTISONE - UNII:WI4X0X7BPJ) | HYDROCORTISONE | 100 mg in 2 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU) | |
| SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA009866 | 04/27/1955 | |
|
| Part 22 of 29 |
SOLU-CORTEF
hydrocortisone sodium succinate injection, powder, for solution |
|
| Product Information |
| Item Code (Source) | NDC: 0009-0011 |
| Route of Administration | INTRAMUSCULAR, INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| HYDROCORTISONE SODIUM SUCCINATE (UNII: 50LQB69S1Z) (HYDROCORTISONE - UNII:WI4X0X7BPJ) | HYDROCORTISONE | 100 mg in 2 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU) | |
| SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA009866 | 04/27/1955 | |
|
| Part 23 of 29 |
FUROSEMIDE
furosemide injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 23155-473 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) | FUROSEMIDE | 10 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA203428 | 09/02/2014 | |
|
| Part 24 of 29 |
FUROSEMIDE
furosemide injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 63323-280 |
| Route of Administration | INTRAVENOUS, INTRAMUSCULAR |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) | FUROSEMIDE | 10 mg in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| SODIUM CHLORIDE (UNII: 451W47IQ8X) | |
| SODIUM HYDROXIDE (UNII: 55X04QC32I) | |
| HYDROCHLORIC ACID (UNII: QTT17582CB) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA018902 | 07/12/2000 | |
|
| Part 25 of 29 |
FUROSEMIDE
furosemide injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 36000-283 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| FUROSEMIDE (UNII: 7LXU5N7ZO5) (FUROSEMIDE - UNII:7LXU5N7ZO5) | FUROSEMIDE | 10 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA202747 | 02/06/2014 | |
|
| Part 26 of 29 |
PITOCIN
oxytocin injection |
|
| Product Information |
| Item Code (Source) | NDC: 42023-116 |
| Route of Administration | INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| OXYTOCIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN) | OXYTOCIN | 10 [iU] in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| ACETIC ACID (UNII: Q40Q9N063P) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA018261 | 02/01/2008 | |
|
| Part 27 of 29 |
OXYTOCIN
oxytocin injection, solution |
|
| Product Information |
| Item Code (Source) | NDC: 63323-012 |
| Route of Administration | INTRAVENOUS, INTRAMUSCULAR |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| OXYTOCIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN) | OXYTOCIN | 10 [USP'U] in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| ACETIC ACID (UNII: Q40Q9N063P) | |
| CHLOROBUTANOL (UNII: HM4YQM8WRC) | |
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NDA | NDA018248 | 08/10/2000 | |
|
| Part 28 of 29 |
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride injection |
|
| Product Information |
| Item Code (Source) | NDC: 0641-1495 |
| Route of Administration | INTRAMUSCULAR, INTRAVENOUS |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| PROMETHAZINE HYDROCHLORIDE (UNII: R61ZEH7I1I) (PROMETHAZINE - UNII:FF28EJQ494) | PROMETHAZINE HYDROCHLORIDE | 25 mg in 1 mL |
|
|
|
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA083312 | 09/19/1973 | |
|
| Part 29 of 29 |
METOPROLOL TARTRATE
metoprolol tartrate tablet, film coated |
|
| Product Information |
| Item Code (Source) | NDC: 65862-062 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| METOPROLOL TARTRATE (UNII: W5S57Y3A5L) (METOPROLOL - UNII:GEB06NHM23) | METOPROLOL TARTRATE | 25 mg |
|
|
|
| Product Characteristics |
| Color | white | Score | 2 pieces |
| Shape | ROUND | Size | 7mm |
| Flavor | | Imprint Code |
C;73
|
| Contains | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA077739 | 09/11/2007 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| exempt device | ABC | 01/01/2015 | 10/25/2024 |
|
